Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

16.03
Delayed Data
As of 4:00pm ET
 -0.36 / -2.20%
Today’s Change
12.61
Today|||52-Week Range
120.96
-27.99%
Year-to-Date
No recent news for Esperion Therapeutics Inc.

Today’s Trading

Previous close16.39
Today’s open16.51
Day’s range15.56 - 16.68
Volume265,243
Average volume (3 months)506,393
Market cap$369.4M
Dividend yield--
Data as of 4:00pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)-1.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+22.06%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd-0.05-0.29%
CGENCompugen Ltd0.000.00%
XBITXBiotech Inc+0.24+1.88%
BPMCBlueprint Medicines ...+0.66+4.35%
Data as of 4:00pm ET, 05/02/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$0.00
Annual profit (last year)-$49.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

Partner Offers

Search for Jobs